Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Repayments (2012 - 2025)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Long-Term Debt Repayments came in at $9.6 million in Q1 2025, up 4006.38% year-on-year from $235000.0 in Q1 2024, and up 1268.79% quarter-over-quarter from $705000.0 in Q4 2024.
Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Repayments (2012 - 2025) Analysis & Trends
Tonix Pharmaceuticals Holding's Long-Term Debt Repayments history runs 3 years deep, the most recent figure standing at $9.6 million for Q1 2025.
- On a quarterly basis, Long-Term Debt Repayments rose 4006.38% year-over-year to $9.6 million in Q1 2025; TTM through Dec 2025 was $9.6 million, a 310.64% increase from a year earlier, with the FY2025 full-year figure at $9.6 million, up 310.64% from the prior year.
- Long-Term Debt Repayments improved to $9.6 million in Q1 2025 per TNXP's latest filing, from $705000.0 in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $9.6 million in Q1 2025 and bottomed at $235000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 7.64 Mn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | - |
| 10 | Tonix Pharmaceuticals Holding | 140.36 Mn | 140.36 Mn | 5.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 9.65 Mn |
| Mar 31, 2025 | 9.65 Mn |
| Dec 31, 2024 | 705,000.00 |
| Dec 31, 2024 | 705,000.00 |
| Sep 30, 2024 | 705,000.00 |
| Sep 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 235,000.00 |
| Mar 31, 2024 | 235,000.00 |
| Mar 31, 2012 | 150,000.00 |
| Mar 31, 2012 | 150,000.00 |